1-11 of 11
Marc Schmitz, MD
Close
Sort by
Journal Articles

Immune Landscapes Predict Chemotherapy Resistance and Anti-Leukemic Activity of Flotetuzumab, an Investigational CD123×CD3 Bispecific Dart® Molecule, in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Jayakumar Vadakekolathu, PhD, Mark D. Minden, MD PhD, Tressa Hood, MSc, Sarah E. Church, PhD, Stephen Reeder, BSc, Heidi Altmann, PhD, Amy H Sullivan, BSc, Elena J Viboch, MSc, Tasleema Patel, Narmin Ibrahimova, Sarah E. Warren, PhD, Andrea Arruda, Marc Schmitz, MD, Yan Liang, PhD, Alessandra Cesano, MD PhD, A. Graham Pockley, PhD, Peter Valk, PhD, Bob Löwenberg, MD PhD, Martin Bornhäuser, MD, Sarah K. Tasian, MD, Michael P. Rettig, PhD, Jan K Davidson-Moncada, MD PhD, John F. DiPersio, MD PhD, Sergio Rutella, MDPhDFRCPath
Journal: Blood
Blood (2019) 134 (Supplement_1): 460.
https://doi.org/10.1182/blood-2019-121870
Published: 2019
Journal Articles

Targeting Intracellular WT1 in AML Utilizing a T Cell Bispecific Antibody Construct: Augmenting Efficacy through Combination with Lenalidomide

Christian Klein, PhD, Christian Augsberger, Wei Xu, MD PhD, Christina Heitmüller, PhD, Lydia Hanisch, PhD, Johannes Sam, PhD, Vesna Pulko, PhD, Anne Schönle, John Challier, PhD, Alejandro Carpy, PhD, Nikola Konstandin, PhD, Maurine Rothe, Gerulf Hänel, Veit Bücklein, MD, Felix S. Lichtenegger, MD, Antje Tunger, PhD, Marc Schmitz, MD, Michael von Bergwelt, Karsten Spiekermann, MD, Pablo Umana, PhD, Marion Subklewe, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4450.
https://doi.org/10.1182/blood-2019-130121
Published: 2019
Journal Articles

Targeting the FMS-like Tyrosin Kinase 3 with the Unicar System: Preclinical Comparison of Murine and Humanized Single-Chain Variable Fragment-Based Targeting Modules

Frederick Fasslrinner, MD, Claudia Arndt, PhD, Anja Feldmann, PhD, Stefanie Koristka, PhD, Liliana Raquel Loureiro, PhD, Marc Schmitz, MD, Gundram Jung, MD, Martin Bornhaeuser, MD, Michael Bachmann, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5614.
https://doi.org/10.1182/blood-2019-124279
Published: 2019
Journal Articles

Immune Gene Expression Profiling in Children and Adults with Acute Myeloid Leukemia Identifies Distinct Phenotypic Patterns

Jayakumar Vadakekolathu, PhD, Tasleema Patel, BSc, Stephen Reeder, BSc, Heidi Schaarschmidt, BSc, Marc Schmitz, MD, Martin Bornhäuser, MD, Sarah E. Warren, PhD, Tressa Hood, MS, Patrick Danaher, PhD, Alessandra Cesano, Joseph M. Beechem, PhD, A. Graham Pockley, PhD, Sarah K Tasian, MD, Sergio Rutella, MDPhDFRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 3942.
https://doi.org/10.1182/blood.V130.Suppl_1.3942.3942
Published: 2017
Journal Articles

Influence Of Steroid Exposure On CMV Specific T Cells Following Allogeneic Stem Cell Transplantation

Cornelia S. Link, MD, Elke Rücker-Braun, PhD, Sebastian Tuve, MD, Sarah Matko, Marc Schmitz, MD, Rebekka Wehner, PhD, Antje Tunger, Katja Sockel, MD, Stefani Parmentier, MD, Jan Moritz Middeke, MD, Änne Boldt, MD, Johannes Schetelig, MD, M. Sc,, Markus Odendahl, PhD, Torsten Tonn, MD, Martin Bornhäuser, MD, Falk Heidenreich, PhD
Journal: Blood
Blood (2013) 122 (21): 5488.
https://doi.org/10.1182/blood.V122.21.5488.5488
Published: 2013
Journal Articles

Screening For Anti-Leukemic CTLs After Allogeneic Hematopoietic Stem Cell Transplantation Applying Streptamer Technology

Falk Heidenreich, PhD, Elke Rücker-Braun, PhD, Sebastian Tuve, MD, Marc Schmitz, MD, Rebekka Wehner, PhD, Antje Tunger, Marcus Odendahl, PhD, Tonn Torsten, MD, Martin Bornhäuser, MD, Johannes Schetelig, MD, M. Sc, Cornelia S. Link, MD
Journal: Blood
Blood (2013) 122 (21): 5493.
https://doi.org/10.1182/blood.V122.21.5493.5493
Published: 2013
Journal Articles

Response and Long-Term Outcome After Treatment With Third-Party Mesenchymal Stromal Cells - Updated Results In 58 Patients With Steroid-Refractory Acute Graft-Versus Host Disease -

Felix von Dalowski, Michael Kramer, PhD, Martin Wermke, MD, Christoph Röllig, MD, Nael Alakel, MD, Friedrich Stölzel, MD, Stefani Parmentier, MD, Katja Sockel, MD, Mathias Krech, PhD, Marc Schmitz, MD, Uwe Platzbecker, MD, PhD, Johannes Schetelig, MD, M. Sc, Martin Bornhauser, MD, Malte von Bonin, MD
Journal: Blood
Blood (2013) 122 (21): 4612.
https://doi.org/10.1182/blood.V122.21.4612.4612
Published: 2013
Journal Articles

Reconstitution of IL-17-Producing T Helper Cells After Allogeneic Hematopoietic Cell Transplantation

Sebastian Tuve, MD, Felix Bahr, Rebekka Wehner, PhD, Uwe Platzbecker, MD, Martin Wermke, MD, Nona Shayegi, MD, Jan Moritz Middeke, MD, Christoph Röllig, Johannes Schetelig, Gerhard Ehninger, Marc Schmitz, MD, Martin Bornhäuser, MD
Journal: Blood
Blood (2012) 120 (21): 4167.
https://doi.org/10.1182/blood.V120.21.4167.4167
Published: 2012
Journal Articles

Azacytidine Compromises NK-Cell Activity in AML and MDS Patients Undergoing MRD-Based Pre-Emptive Treatment After Allogeneic Stem Cell Transplantation

Katja Sockel, MD, Claudia Schönefeldt, MSc, Sieghart Sopper, Martin Wermke, MD, Marc Schmitz, MD, Gerhard Ehninger, Martin Bornhäuser, MD, Dominik Wolf, MD, Uwe Platzbecker, MD
Journal: Blood
Blood (2012) 120 (21): 4122.
https://doi.org/10.1182/blood.V120.21.4122.4122
Published: 2012
Journal Articles

Differences in Reconstitution of NK-Cell Subsets and Expression of Effector Molecules after HLA-Identical and Haploidentical Allogeneic Stem Cell Transplantation in Patients with AML.

Uwe Platzbecker, MD, Astrid Schulze, Uta Oelschlagel, MD, Holger Schirutschke, Marc Schmitz, MD, Gerhard Ehninger, MD, Martin Bornhauser, MD
Journal: Blood
Blood (2005) 106 (11): 1411.
https://doi.org/10.1182/blood.V106.11.1411.1411
Published: 2005
Journal Articles

Tumoricidal Potential of Native Human Blood Dendritic Cells: Direct Tumor Cell Killing and Activation of NK Cell-Mediated Cytotoxicity.

Marc Schmitz, MD, Senming Zhao, MD, Yvonne Deuse, Knut Schaekel, MD, Martin Bornhaeuser, MD, Peter Rieber, MD
Journal: Blood
Blood (2004) 104 (11): 449.
https://doi.org/10.1182/blood.V104.11.449.449
Published: 2004